BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26476890)

  • 1. [Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation?].
    Sénéchal C; Rousset-Jablonski C
    Gynecol Obstet Fertil; 2015 Dec; 43(12):800-5. PubMed ID: 26476890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation in BRCA mutation carriers.
    Revelli A; Salvagno F; Delle Piane L; Casano S; Evangelista F; Pittatore G; Razzano A; Marchino GL; Gennarelli G; Benedetto C
    Minerva Ginecol; 2016 Oct; 68(5):587-601. PubMed ID: 26997146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in BRCA-mutated women: when and how?
    Grynberg M; Raad J; Comtet M; Vinolas C; Cédrin-Durnerin I; Sonigo C
    Future Oncol; 2018 Feb; 14(5):483-490. PubMed ID: 29327596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
    Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
    Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA mutations and reproduction.
    Daum H; Peretz T; Laufer N
    Fertil Steril; 2018 Jan; 109(1):33-38. PubMed ID: 29307397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI).
    La Marca A; Mastellari E
    J Assist Reprod Genet; 2021 Apr; 38(4):759-777. PubMed ID: 33495935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women.
    de la Noval BD
    Arch Gynecol Obstet; 2016 Nov; 294(5):1099-1103. PubMed ID: 27561295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
    Turan V; Oktay K
    Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility preservation in breast cancer patients.
    El Hachem H; Atallah D; Grynberg M
    Future Oncol; 2014 Aug; 10(10):1767-77. PubMed ID: 25303056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age.
    Tea MK; Weghofer A; Wagner K; Singer CF
    Maturitas; 2013 Jun; 75(2):148-51. PubMed ID: 23528734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA Mutations and Fertility Preservation.
    Dias Nunes J; Demeestere I; Devos M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
    Gronwald J; Glass K; Rosen B; Karlan B; Tung N; Neuhausen SL; Moller P; Ainsworth P; Sun P; Narod SA; Lubinski J; Kotsopoulos J;
    Fertil Steril; 2016 Mar; 105(3):781-785. PubMed ID: 26698676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
    Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
    Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
    Merlino L; Chiné A; Galli C; Piccioni MG
    Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
    Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
    Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility and pregnancy issues in BRCA-mutated breast cancer patients.
    Lambertini M; Goldrat O; Toss A; Azim HA; Peccatori FA; Ignatiadis M; Del Mastro L; Demeestere I
    Cancer Treat Rev; 2017 Sep; 59():61-70. PubMed ID: 28750297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.